Profile

New User

New to Graphy Publications? Create an account to get started today.

Registered Users

Have an account? Sign in now.

How to Cite | Author Information | Publication History | Funding Information
International Journal of Clinical Pharmacology & Pharmacotherapy Volume 1 (2016), Article ID 1:IJCPP-103, 5 pages
https://doi.org/10.15344/2456-3501/2016/103
Research Article
Evaluation of Concordance Among Different Drug Information Sources Regarding the Recommendations for Dosage Adjustment in Renal Impairment

Kyung Hee Choi1,6, Young-Mi Ah2, Soo-in Sun3, Juyun Kim4, Jinjoo Lee5, Sooyoung Shin3, Ju-Yeun Lee2 and Sukhyang Lee3*

1College of Pharmacy, Sunchon National University, Suncheon, South Korea
2College of Pharmacy, Institute of Pharmaceutical Science and Technology, Hanyang University, Ansan, South Korea
3College of Pharmacy, Ajou University, Suwon, South Korea
4Department of Biomedical Science, College of Medicine, Seoul National University, Seoul
5Florida Hospital East Orlando, Orlando, FL
6College of Pharmacy, Chonnam National University, Gwang-Ju, South Korea
Dr. Sukhyang Lee, College of Pharmacy, Ajou University, Woncheon-dong, Yeongtong-gu, Suwon 16499, South Korea; E-mail: suklee@ajou.ac.kr
19 November 2015; 16 February 2016; 18 February 2016
Choi KH, Ah YM, Sun SI, Kim J, Lee J, et al. (2016) Evaluation of Concordance Among Different Drug Information Sources Regarding the Recommendations for Dosage Adjustment in Renal Impairment. Int J Clin Pharmacol Pharmacother 1: 103. doi: https://doi.org/10.15344/2456-3501/2016/103
This study was supported by a grant of the Korea Healthcare R&D Project, the Ministry of Health & Welfare, Republic of Korea (Grant No. HI13C0723).
© 2016 Choi et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

References

  1. Choi N, Lee JY, Cho YS, Kim HS, Son IJ, Lee HS (2011) Assessing prescribing behavior in hospitalized patients with renal impairment. J Kor Soc Health-Syst Pharm 28:13
  2. Chertow GM, Lee J, Kuperman GJ, Burdick E, Horsky J, Seger DL, et al. (2001) Guided medication dosing for inpatients with renal insufficiency. JAMA 286: 2839-2844 [CrossRef] [Google Scholar] [PubMed]
  3. Karras DJ (1994) Severe low back pain secondary to acute interstitial nephritis following administration of ranitidine. The American journal of emergency medicine.12: 67-68 [CrossRef] [Google Scholar] [PubMed]
  4. Slugg PH, Haug MT, Pippenger CE (1992) Ranitidine pharmacokinetics and adverse central nervous system reactions. Arch Intern Med 152: 2325- 2329 [CrossRef] [Google Scholar] [PubMed]
  5. Calandra G, Lydick E, Carrigan J, Weiss L, Guess H (1988) Factors predisposing to seizures in seriously ill infected patients receiving antibiotics: experience with imipenem/cilastatin. The American journal of medicine 84: 911-918 [CrossRef] [Google Scholar] [PubMed]
  6. Ryu JH, Kyoung EJ, Lee HY, Oh M, Kim EY (2012) Comparative Analysis of Drug InformationResources for Dose Adjustment in terms of Renal and Hepatic Function. Kor J Clin Pharm 22 [Google Scholar]
  7. Salgado TM, Arguello B, Martinez-Martinez F, Benrimoj SI, Fernandez- Llimos F (2013) Clinical relevance of information in the Summaries of Product Characteristics for dose adjustment in renal impairment. European journal of clinical pharmacology. 69: 1973-1979 [CrossRef] [Google Scholar] [PubMed]
  8. Korean National Formulary, 2011
  9. Khanal A, Castelino RL, Peterson GM, Jose MD (2013) Dose adjustment guidelines for medications in patients with renal impairment: how consistent are drug information sources? Intern Med J 44: 77-85 [CrossRef] [Google Scholar] [PubMed]
  10. The Regents of the University of California, 2014
  11. David McAuley PD, The Clinician's Ultimate Reference
  12. BNF (2013) British National Formulary 65
  13. DailyMed: U.S. the National Library of Medicine; 2014
  14. Lexicomp-online (2013) Wolters Kluwer Health
  15. Swan SK, Bennett WM (2007) Drug dosing guidelines in patients with renal failure. West J med 156 [Google Scholar] [PubMed]
  16. Vidal L, Shavit M, Fraser A, Paul M, Leibovici L (2005) Systematic comparison of four sources of drug information regarding adjustment of dose for renal function. BMJ 331: 263 [CrossRef] [Google Scholar] [PubMed]
  17. Landis JR, Koch GG (1977) The Measurement of Observer Agreement for Categorical Data. Biometrics 33: 159-174 [Google Scholar] [PubMed]
  18. http://en.wikipedia.org/wiki/Fleiss%27_kappa
  19. Zaiontz C (2014) Real Statistics Using Excel [View]
  20. Phillips DP, Christenfeld N, Glynn LM (1998) Increase in US medicationerror deaths between 1983 and 1993. Lancet 351: 643-644 [CrossRef] [Google Scholar] [PubMed]
  21. Franchi D, Cini D, Iervasi G (2011) A new Web-based medical tool for assessment and prevention of comprehensive cardiovascular risk. Ther Clin Risk Manag 7: 59-68 [CrossRef] [Google Scholar] [PubMed]
  22. Seo J, Lee E, Lee J, Cho K, Ham J (2010) Evaluation of Clinical Decision Supporting System as part of the Order Communication System. J Kor Soc Health-Syst Pharm 27
Best viewed in Mozilla Firefox, Google Chrome, Safari, Above IE 9.0 version
Privacy Policy | Copyright & Permissions
Copyright © 2013-2024 Graphy Publications, All Rights Reserved.